Mitesco (MITI) Gross Margin (2011 - 2022)

Mitesco (MITI) reported Gross Margin of 258.51% for Q2 2022, down 31478.0% year-over-year from N/an in Q2 2021, and up 33.5% quarter-over-quarter from 388.74% in Q1 2022.

Mitesco (MITI) Gross Margin (2011 - 2022) Analysis & Trends

Mitesco (MITI) has 7 years of Gross Margin data on file, last reported at 258.51% in Q2 2022.

  • Gross Margin for Q2 2022 came in at 258.51%, down 31478.0% year-over-year; the trailing twelve-month figure through Mar 2023 was 259.94% (up 8659.0% YoY), and the FY2021 annual result was 292.77%, changed N/A from the prior year.
  • Gross Margin improved to 258.51% in Q2 2022 per MITI's latest filing, from 388.74% in the prior quarter.
  • Over five years, Gross Margin peaked at 81.62% in Q3 2021 and troughed at 390.72% in Q4 2021.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Veeva Systems 24.83 Bn 17.52 Bn 662.02 Mn 74.98%
2 BrightSpring Health Services 13.57 Bn 12.69 Bn 482.22 Mn 13.34%
3 Healthequity 7.20 Bn 6.93 Bn 256.31 Mn 72.27%
4 Hinge Health 5.42 Bn 5.11 Bn 154.23 Mn 84.60%
5 10x Genomics 4.46 Bn 3.92 Bn 106.18 Mn 70.39%
6 Doximity 3.81 Bn 3.06 Bn 125.97 Mn 86.65%
7 Waystar Holding 3.52 Bn 3.36 Bn 268.04 Mn 85.40%
8 Privia Health 2.94 Bn 2.57 Bn 595.71 Mn 98.65%
9 Omnicell 1.76 Bn 1.59 Bn 140.36 Mn 45.30%
10 Mitesco - - - -

Historic Data

Download Data
DateValue
Jun 30, 2022 -258.51%
Mar 31, 2022 -388.74%
Dec 31, 2021 -390.72%
Sep 30, 2021 81.62%
Jun 30, 2021 56.27%
Mar 31, 2021 42.36%
Sep 30, 2015 45.84%
Jun 30, 2015 45.84%
Mar 31, 2015 47.65%
Dec 31, 2014 32.64%
Sep 30, 2014 25.24%
Jun 30, 2014 25.24%
Mar 31, 2014 19.46%
Dec 31, 2013 53.38%
Sep 30, 2013 65.44%
Jun 30, 2013 92.25%
Mar 31, 2013 50.27%
Dec 31, 2012 53.75%
Sep 30, 2012 61.00%
Jun 30, 2012 71.18%